Finalità:

Scadrà il 26 Luglio 2016 il termine ultimo per la presentazione di progetti nell'ambito della nona Call del Programma IMI2 di Horizon 2020 - Societal Challenges.

I topic sono:

-IMI2-2016-09-01:”Addressing the clinical burden of Clostridium difficile infection (CDI)…Evaluation of the burden, current practices and set-up of a European research platform”;

-IMI2-2016-09-02:”Development of immune tolerance therapies for the treatment of rheumatic diseases”;

-IMI2-2016-09-03:”Data quality in preclinical research and development”;

-IMI2-2016-09-04:”Next generation of electronic translational safety – NexGETS”;

-IMI2-2016-09-05:”Identification and validation of biomarkers for nonalcoholic steatohepatitis (NASH) and across the spectrum of non-alcoholic fatty liver disease (NAFLD)”;

-IMI2-2016-09-06:”Joint influenza vaccine effectiveness studies”.

Stanziamento: 

Una parte del budget sarà sostenuta dalla Commissione Europea tramite Horizon2020, la restante dalle Aziende EFPIA coinvolte nei progetti.

Tratto da:

Link:

http://ec.europa.eu/research/participants/portal/desktop/en/home.html